Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.

Multiple Sclerosis (MS) is a demyelinating/inflammatory disease of the central nervous system. Relapsing-remitting MS is characterized by a relapsing phase with clinical symptoms and the production of inflammatory cell infiltrates, and a period of remission during which patients recover partially. M...

Descripción completa

Detalles Bibliográficos
Autores: Moliné-Velázquez, Verónica, Cuervo, Henar, Vila-Del Sol, Virginia, Ortega, María Cristina, Clemente, Diego, de Castro, Fernando
Tipo de recurso: artículo
Fecha de publicación:2011
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/17194
Acceso en línea:http://hdl.handle.net/20.500.12105/17194
Access Level:acceso abierto
Palabra clave:Animals
Apoptosis
Arginase
Encephalomyelitis, Autoimmune, Experimental
Female
Immune Tolerance
Immunohistochemistry
Inflammation
Mice
Mice, Inbred C57BL
Multiple Sclerosis, Relapsing-Remitting
Myeloid Cells
Spinal Cord
T-Lymphocytes
id ES_b4e1447f926eaa0e80a05dd8b50eaaa9
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/17194
network_acronym_str ES
network_name_str España
repository_id_str
spelling Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.Moliné-Velázquez, VerónicaCuervo, HenarVila-Del Sol, VirginiaOrtega, María CristinaClemente, Diegode Castro, FernandoAnimalsApoptosisArginaseEncephalomyelitis, Autoimmune, ExperimentalFemaleImmune ToleranceImmunohistochemistryInflammationMiceMice, Inbred C57BLMultiple Sclerosis, Relapsing-RemittingMyeloid CellsSpinal CordT-LymphocytesMultiple Sclerosis (MS) is a demyelinating/inflammatory disease of the central nervous system. Relapsing-remitting MS is characterized by a relapsing phase with clinical symptoms and the production of inflammatory cell infiltrates, and a period of remission during which patients recover partially. Myeloid-derived suppressor cells (MDSCs) are immature cells capable of suppressing the inflammatory response through Arginase-I (Arg-I) activity, among other mechanisms. Here, we have identified Arg-I(+) -MDSCs in the spinal cord during experimental autoimmune encephalomyelitis (EAE), cells that were largely restricted to the demyelinating plaque and that always exhibited the characteristic MDSC surface markers Arg-I/CD11b/Gr-1/M-CSF1R. The presence and density of Arg-I(+) -cells, and the proportion of apoptotic but not proliferative T cells, were correlated with the EAE time course: peaked in parallel with the clinical score, decreased significantly during the remitting phase and completely disappeared during the chronic phase. Spinal cord-isolated MDSCs of EAE animals augmented the cell death when co-cultured with stimulated control splenic CD3 T cells. These data point to an important role for MDSCs in limiting inflammatory damage in MS, favoring the relative recovery in the remitting phase of the disease. Thus, the MDSC population should be considered as a potential therapeutic target to accelerate the recovery of MS patients.Wiley20242024-01-1720112011-11-0120112011-11-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/17194reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/171942026-06-12T12:43:37Z
dc.title.none.fl_str_mv Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
title Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
spellingShingle Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
Moliné-Velázquez, Verónica
Animals
Apoptosis
Arginase
Encephalomyelitis, Autoimmune, Experimental
Female
Immune Tolerance
Immunohistochemistry
Inflammation
Mice
Mice, Inbred C57BL
Multiple Sclerosis, Relapsing-Remitting
Myeloid Cells
Spinal Cord
T-Lymphocytes
title_short Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
title_full Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
title_fullStr Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
title_full_unstemmed Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
title_sort Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
dc.creator.none.fl_str_mv Moliné-Velázquez, Verónica
Cuervo, Henar
Vila-Del Sol, Virginia
Ortega, María Cristina
Clemente, Diego
de Castro, Fernando
author Moliné-Velázquez, Verónica
author_facet Moliné-Velázquez, Verónica
Cuervo, Henar
Vila-Del Sol, Virginia
Ortega, María Cristina
Clemente, Diego
de Castro, Fernando
author_role author
author2 Cuervo, Henar
Vila-Del Sol, Virginia
Ortega, María Cristina
Clemente, Diego
de Castro, Fernando
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv Animals
Apoptosis
Arginase
Encephalomyelitis, Autoimmune, Experimental
Female
Immune Tolerance
Immunohistochemistry
Inflammation
Mice
Mice, Inbred C57BL
Multiple Sclerosis, Relapsing-Remitting
Myeloid Cells
Spinal Cord
T-Lymphocytes
topic Animals
Apoptosis
Arginase
Encephalomyelitis, Autoimmune, Experimental
Female
Immune Tolerance
Immunohistochemistry
Inflammation
Mice
Mice, Inbred C57BL
Multiple Sclerosis, Relapsing-Remitting
Myeloid Cells
Spinal Cord
T-Lymphocytes
description Multiple Sclerosis (MS) is a demyelinating/inflammatory disease of the central nervous system. Relapsing-remitting MS is characterized by a relapsing phase with clinical symptoms and the production of inflammatory cell infiltrates, and a period of remission during which patients recover partially. Myeloid-derived suppressor cells (MDSCs) are immature cells capable of suppressing the inflammatory response through Arginase-I (Arg-I) activity, among other mechanisms. Here, we have identified Arg-I(+) -MDSCs in the spinal cord during experimental autoimmune encephalomyelitis (EAE), cells that were largely restricted to the demyelinating plaque and that always exhibited the characteristic MDSC surface markers Arg-I/CD11b/Gr-1/M-CSF1R. The presence and density of Arg-I(+) -cells, and the proportion of apoptotic but not proliferative T cells, were correlated with the EAE time course: peaked in parallel with the clinical score, decreased significantly during the remitting phase and completely disappeared during the chronic phase. Spinal cord-isolated MDSCs of EAE animals augmented the cell death when co-cultured with stimulated control splenic CD3 T cells. These data point to an important role for MDSCs in limiting inflammatory damage in MS, favoring the relative recovery in the remitting phase of the disease. Thus, the MDSC population should be considered as a potential therapeutic target to accelerate the recovery of MS patients.
publishDate 2011
dc.date.none.fl_str_mv 2011
2011-11-01
2011
2011-11-01
2024
2024-01-17
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/17194
url http://hdl.handle.net/20.500.12105/17194
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417297094901760
score 15,812429